http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4158ee58e5e8708a3fa88a13ead6066
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Chi |
| name | Andrew S Chi Andrew S. Chi |
| given-name | Andrew S Andrew S. |
| organization-name | Molecular Pathology Unit and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA 02129, USA.; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Stephen E. and Catherine Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA. 10Department of Neurosurgery, NYU Langone Medical Center, New York, New York.; 11Division of Neuro-Oncology, NYU Langone Medical Center, New York, New York. 14Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York University, New York, New York. From the Department of Medicine, Division of Cardiology (S.L., R.M., D.J.D., M.Z., J.M.Z., K.H.S., A.S.C., J.M.H.); The Institute for Cell Engineering (ICE) (S.L., R.M., D.J.D., M.Z., J.M.Z., K.H.S., A.S.C., J.M.H.); and the Department of Comparative Medicine (D.B., J.M.H.), Johns Hopkins University School of Medicine, Baltimore, Md. Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, NY, USA Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, New York, USA 5Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York. Perlmutter Cancer Center, NYU Langone Health, New York, United States; Department of Neurology, NYU Langone Health, New York, United States Division of NeuroâOncology Massachusetts General Hospital Boston Massachusetts 2Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, New York.; 3Department of Neurosurgery, NYU Langone Health, New York, New York. Department of Neurology, Massachusetts General Hospital , Boston, Massachusetts , USA Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, New York, New York. Massachusetts General Hospital, Harvard Medical School Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 8Stephen E. and Catherine Pappas Center for Neuro-Oncology, Division of Hematology/Oncology, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. 15Mirati Therapeutics, San Diego, California. Neurology, New York, New York, USA; Laura and Isaac Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, New York, USA; Brain and Spine Tumor Center, NYU Grossman School of Medicine, New York, New York, USA Mirati Therapeutics, San Diego, CA, USA Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center New York NY 3Translational Neuro-Oncology Laboratory, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.; 8Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York. New York University School of Medicine, New York, NY Departments of Laboratory Medicine and Pathology, Yale University School of Medicine, New Haven, Connecticut Massachusetts General Hospital and Harvard Medical School, Boston, MA 1Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; 4Department of Neurology, Harvard Medical School, Boston, Massachusetts. NYU Langone Medical Center and School of Medicine, New York, New York Stephen E. and Catherine Pappas Center for Neuro-Oncology, Department of Neurology, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA Laura and Isaac Perlmutter Cancer Center and Brain Tumor Center, NYU Langone Medical Center and School of Medicine, New York, NY, USA Department of Neurology, Massachusetts General Hospital, Boston, MA, USA. Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine and New York University Langone Health, New York, NY 10016; Authors' Affiliations: 1Department of Neurosurgery; 2Division of Hematology/Oncology, Department of Neurology, Stephen E. and Catherine Pappas Center for Neuro-Oncology, 3Translational Research Laboratory; 4Department of Pathology; 5Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge; 6Translational Neuro-Oncology Laboratory; 7Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; 8Vesalius Research Center, VIB and Department of Oncology, KU Leuven, Leuven, Belgium; Authors' Affiliations: 1Department of Neurosurgery; 2Division of Hematology/Oncology, Department of Neurology, Stephen E. and Catherine Pappas Center for Neuro-Oncology, 3Translational Research Laboratory; 4Department of Pathology; 5Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge; 6Translational Neuro-Oncology Laboratory; 7Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; 8Vesalius Research Center, VIB and Department of Oncology, KU Leuven, Leuven, Belgium; Authors' Affiliations: 1Department of Neurosurgery; 2Division of Hematology/Oncology, Department of Neurology, Stephen E. and Catherine Pappas Center for Neuro-Oncology, 3Translational Research Laboratory; 4Department of Pathology; 5Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge; 6Translational Neuro-Oncology Laboratory; 7Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; 8Vesalius Research Center, VIB and Department of Oncology, KU Leuven, Leuven, Belgium Neuro-Oncology Program, Perlmutter Cancer Center, NYU Langone Health, New York, New York Department of Neurology, Division of Neuro-Oncology, Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York, USA Stephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA f Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA; g Division of Hematology/Oncology, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA Mirati Therapeutics, San Diego, California, USA |
Incoming Links
Total number of triples: 123.